BBIO R&D Expenses
Bridgebio Pharma Inc · R&D Expenses
BBIO R&D Expenses
Latest reported$530.96Mperiod ending
BBIO TTM R&D Expenses ($140.07M → $530.96M)
TTM R&D Expenses
High-resolution chart · PNG
BBIO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 530,958,000 | |
| 492,741,000 | |
| 477,536,000 | |
| 465,886,000 | |
| 473,456,000 | |
| 476,920,000 | |
| 506,461,000 | |
| 506,337,000 | |
| 511,029,000 | |
| 503,822,000 | |
| 455,711,000 | |
| 416,387,000 | |
| 383,762,000 | |
| 384,674,000 | |
| 399,462,000 | |
| 430,760,000 | |
| 442,554,000 | |
| 436,114,000 | |
| 451,024,000 | |
| 418,998,000 | |
| 406,743,000 | |
| 391,381,000 | |
| 337,047,000 | |
| 304,358,000 | |
| 267,586,000 | |
| 233,319,000 | |
| 209,947,000 | |
| 203,664,000 | |
| 179,534,000 | |
| 151,095,000 | |
| 140,073,000 |